C-MER Medical announces share repurchase; treasury holdings increase

C-MER Medical Holdings Limited reported a change in its issued share capital due to a share repurchase on October 23, 2025. The company repurchased 230,000 ordinary shares on the Exchange at prices ranging from HK$1.90 to HK$1.92, with an aggregate price paid of HK$439,600. These repurchased shares are being held as treasury shares, increasing the total number of treasury shares from 13,214,000 to 13,444,000.

The repurchase resulted in a 0.0185% reduction in issued shares (excluding treasury shares) from the opening balance of 1,242,346,870 on October 22, 2025. Following this transaction, the closing balance of issued shares (excluding treasury shares) as of October 23, 2025, stands at 1,242,116,870. The total number of issued shares remains unchanged at 1,255,560,870 as the repurchased shares are held in treasury.

The company also disclosed that it has an authorization to repurchase 125,556,087 shares under a mandate granted on May 19, 2025. The 230,000 shares repurchased on October 23, 2025, represent 0.0185% of the issued shares (excluding treasury shares) as of the mandate date.